726518002: Baricitinib (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with effector mechanism of action (substance)\Enzyme inhibitor\Transferase inhibitor\Phosphotransferase inhibitor\Protein kinase inhibitor\Protein-tyrosine kinase inhibitor\Janus kinase inhibitor\Baricitinib (substance)
\Substance categorized by disposition\Immunomodulator\Immunosuppressant (substance)\Baricitinib (substance)

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Immunosuppressant (substance)\Baricitinib (substance)

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\Organic compound\Organic cyclic compound\Bicyclic compound (substance)\Baricitinib (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2017. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

3450089017 Baricitinib (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

3450090014 Baricitinib en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

926281000195115 baricitinib it Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

793411000172110 baricitinib fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

2315571000195112 Baricitinib de Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Baricitinib (substance)	Is a	Immunosuppressant (substance)	true	Inferred relationship	Some
Baricitinib (substance)	Is a	Janus kinase inhibitor	true	Inferred relationship	Some
Baricitinib (substance)	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Janus kinase inhibitor (disposition)	true	Inferred relationship	Some
Baricitinib (substance)	Is a	produit chimique catégorisé selon sa fonction	false	Inferred relationship	Some
Baricitinib (substance)	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	A substance that modifies the immune response or the functioning of the immune system.	true	Inferred relationship	Some
Baricitinib (substance)	Is a	Enzyme inhibitor	false	Inferred relationship	Some
Baricitinib (substance)	Is a	Bicyclic compound (substance)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing baricitinib (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Baricitinib (substance)	Inferred relationship	Some	1
Product containing baricitinib in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Baricitinib (substance)	Inferred relationship	Some	1
Product containing only baricitinib (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Baricitinib (substance)	Inferred relationship	Some	1
Baricitinib only product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Baricitinib (substance)	Inferred relationship	Some	1
Baricitinib 2 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Baricitinib (substance)	Inferred relationship	Some	1
Baricitinib 2 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Baricitinib (substance)	Inferred relationship	Some	1
Baricitinib 4 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Baricitinib (substance)	Inferred relationship	Some	1
Baricitinib 4 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Baricitinib (substance)	Inferred relationship	Some	1
Baricitinib therapy	Direct substance	True	Baricitinib (substance)	Inferred relationship	Some	1

Reference Sets